| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | CACNA2D1 ATG9B ABCA4 ABCA13 SLC35C1 ATP8A2 SLC22A11 PEX5L MCOLN1 SLC1A4 ABCB1 TOMM70 SLC9A2 SLC9A5 ATP8A1 CLCN6 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 PEX2 CACNA1H OSCP1 TMEM109 ZDHHC13 TAP2 SLC4A11 | 2.18e-07 | 1289 | 156 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA2D1 ABCA4 ABCA13 SLC35C1 SLC22A11 PEX5L MCOLN1 SLC1A4 ABCB1 TOMM70 SLC9A2 SLC9A5 ATP8A1 CLCN6 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 PEX2 CACNA1H OSCP1 TMEM109 ZDHHC13 TAP2 SLC4A11 | 4.40e-07 | 1180 | 156 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium channel activity | 3.12e-06 | 52 | 156 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.38e-06 | 14 | 156 | 4 | GO:0140333 | |
| GeneOntologyMolecularFunction | flippase activity | 7.88e-06 | 17 | 156 | 4 | GO:0140327 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 1.60e-05 | 7 | 156 | 3 | GO:0090555 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA4 ABCA13 SLC35C1 SLC22A11 SLC1A4 ABCB1 SLC9A2 SLC9A5 ATP8A1 CLCN6 SLC16A1 SLC15A4 TAP2 SLC4A11 | 2.35e-05 | 477 | 156 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.69e-05 | 26 | 156 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.80e-05 | 51 | 156 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA2D1 PEX5L MCOLN1 SLC1A4 SLC9A2 SLC9A5 ATP8A1 CLCN6 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 CACNA1H TMEM109 ZDHHC13 SLC4A11 | 4.92e-05 | 793 | 156 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.07e-05 | 171 | 156 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 6.34e-05 | 28 | 156 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA2D1 PEX5L MCOLN1 SLC9A2 SLC9A5 ATP8A1 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 CACNA1H TMEM109 ZDHHC13 SLC4A11 | 6.60e-05 | 664 | 156 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.55e-04 | 65 | 156 | 5 | GO:0070063 | |
| GeneOntologyMolecularFunction | floppase activity | 2.43e-04 | 16 | 156 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA2D1 PEX5L MCOLN1 SLC1A4 CLCN6 SCN3A SCN5A SCN10A KCNMA1 CACNA1H TMEM109 SLC4A11 | 2.68e-04 | 459 | 156 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.85e-04 | 74 | 156 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA2D1 SLC22A11 MCOLN1 SLC1A4 SLC9A2 SLC9A5 CLCN6 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 CACNA1H ZDHHC13 SLC4A11 | 2.99e-04 | 758 | 156 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 3.50e-04 | 18 | 156 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.50e-04 | 18 | 156 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | RNA polymerase I core binding | 3.60e-04 | 4 | 156 | 2 | GO:0001042 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA2D1 PEX5L MCOLN1 SCN3A SCN5A SCN10A KCNMA1 CACNA1H TMEM109 SLC4A11 | 3.75e-04 | 343 | 156 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 4.16e-04 | 45 | 156 | 4 | GO:0043175 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC35C1 SLC22A11 SLC1A4 SLC9A2 SLC9A5 CLCN6 SLC16A1 SLC15A4 SLC4A11 | 5.46e-04 | 296 | 156 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.78e-04 | 49 | 156 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 5.97e-04 | 5 | 156 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 5.97e-04 | 5 | 156 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | antiporter activity | 7.60e-04 | 138 | 156 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | cyclase activity | 8.39e-04 | 24 | 156 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | channel activity | CACNA2D1 PEX5L MCOLN1 SLC1A4 CLCN6 SCN3A SCN5A SCN10A KCNMA1 CACNA1H TMEM109 SLC4A11 | 8.80e-04 | 525 | 156 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 8.91e-04 | 6 | 156 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA2D1 PEX5L MCOLN1 SLC1A4 CLCN6 SCN3A SCN5A SCN10A KCNMA1 CACNA1H TMEM109 SLC4A11 | 8.95e-04 | 526 | 156 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.97e-04 | 196 | 156 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 9.48e-04 | 25 | 156 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 1.07e-03 | 26 | 156 | 3 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 1.07e-03 | 26 | 156 | 3 | GO:0019707 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA2D1 MCOLN1 SLC9A2 SLC9A5 SCN3A SCN5A SCN10A KCNMA1 CACNA1H ZDHHC13 SLC4A11 | 1.10e-03 | 465 | 156 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 1.24e-03 | 7 | 156 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA2D1 MCOLN1 SLC9A2 SLC9A5 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 CACNA1H ZDHHC13 SLC4A11 | 1.31e-03 | 627 | 156 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.33e-03 | 28 | 156 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8D1 ADGRG3 OR10A2 NPY5R OR4D10 CCR9 FPR1 OR8S1 ADGRL1 GALR2 MRGPRX1 MTNR1B OR10K2 ADGRA3 OR5F1 OR4F15 | 1.54e-03 | 884 | 156 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 1.63e-03 | 30 | 156 | 3 | GO:0016417 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.66e-03 | 109 | 156 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 2.11e-03 | 9 | 156 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 2.11e-03 | 9 | 156 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 2.11e-03 | 9 | 156 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | GTPase binding | 2.13e-03 | 360 | 156 | 9 | GO:0051020 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 2.34e-03 | 34 | 156 | 3 | GO:0022884 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 2.99e-03 | 37 | 156 | 3 | GO:0016409 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.99e-03 | 37 | 156 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.99e-03 | 37 | 156 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.11e-03 | 182 | 156 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 3.18e-03 | 11 | 156 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.28e-03 | 184 | 156 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | Roundabout binding | 3.80e-03 | 12 | 156 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.80e-03 | 321 | 156 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 4.30e-03 | 42 | 156 | 3 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 4.30e-03 | 42 | 156 | 3 | GO:0004812 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 4.47e-03 | 13 | 156 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | co-receptor binding | 4.47e-03 | 13 | 156 | 2 | GO:0039706 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.82e-03 | 334 | 156 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 5.08e-03 | 337 | 156 | 8 | GO:0031625 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA editing activity | 5.19e-03 | 14 | 156 | 2 | GO:0002161 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 5.19e-03 | 14 | 156 | 2 | GO:0015386 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.29e-06 | 112 | 157 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.47e-06 | 36 | 157 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 8.39e-06 | 63 | 157 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | behavior | MORC1 NPY5R TRH ATP8A2 LRRK2 TPGS1 TSC2 SPG11 GALR2 ADCY1 ADCY8 ATP8A1 SLC16A1 RPTOR MRGPRX1 SCN3A MTNR1B SCN10A KCNMA1 BAIAP3 | 1.48e-05 | 891 | 157 | 20 | GO:0007610 |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 1.48e-05 | 7 | 157 | 3 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 1.48e-05 | 7 | 157 | 3 | GO:0086028 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | NPPA OR8D1 ADGRG3 OR10A2 NPY5R OR4D10 CCR9 FPR1 LRRK2 OR8S1 ADGRL1 RGS21 ZDHHC3 GALR2 ADCY1 ADCY8 ADCY9 SLIT2 MRGPRX1 MTNR1B OR10K2 BAIAP3 DAGLA ADGRA3 OR5F1 OR4F15 | 1.91e-05 | 1395 | 157 | 26 | GO:0007186 |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 2.56e-05 | 23 | 157 | 4 | GO:0009190 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | NPPA MCOLN1 SLC9A2 SLC9A5 SCN3A SCN5A SCN10A CACNA1H SLC4A11 | 3.17e-05 | 208 | 157 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 4.99e-05 | 10 | 157 | 3 | GO:0022028 | |
| GeneOntologyBiologicalProcess | sodium ion transport | NPPA MCOLN1 SLC9A2 SLC9A5 SCN3A SCN5A SCN10A CACNA1H NKAIN1 SLC4A11 | 5.05e-05 | 275 | 157 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | phospholipid translocation | 6.13e-05 | 55 | 157 | 5 | GO:0045332 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 6.83e-05 | 11 | 157 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 7.28e-05 | 180 | 157 | 8 | GO:0120254 | |
| GeneOntologyBiologicalProcess | lipid translocation | 9.34e-05 | 60 | 157 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | 1.11e-04 | 33 | 157 | 4 | GO:0018345 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA2D1 NPPA SLC22A11 SPG11 MCOLN1 GALR2 SLC1A4 ABCB1 MELTF SLC9A2 SLC9A5 ATP8A1 CLCN6 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 CACNA1H NKAIN1 TMEM109 ZDHHC13 SLC4A11 | 1.14e-04 | 1374 | 157 | 24 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.37e-04 | 65 | 157 | 5 | GO:0097035 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 1.72e-04 | 3 | 157 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | membrane depolarization during bundle of His cell action potential | 1.72e-04 | 3 | 157 | 2 | GO:0086048 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 1.84e-04 | 15 | 157 | 3 | GO:0086069 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 9 signaling pathway | 1.84e-04 | 15 | 157 | 3 | GO:0034163 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 2.04e-04 | 209 | 157 | 8 | GO:0006694 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.64e-04 | 217 | 157 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA2D1 NPPA MCOLN1 GALR2 SLC1A4 ABCB1 SLC9A2 SLC9A5 ATP8A1 CLCN6 SLC16A1 SLC15A4 SCN3A SCN5A SCN10A KCNMA1 CACNA1H TMEM109 ZDHHC13 SLC4A11 | 3.18e-04 | 1115 | 157 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.31e-04 | 121 | 157 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 3.42e-04 | 4 | 157 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 3.46e-04 | 44 | 157 | 4 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 3.78e-04 | 45 | 157 | 4 | GO:0009187 | |
| GeneOntologyBiologicalProcess | amide transport | TRH ABCA13 PEX5L ADCY8 ABCB1 SLC16A1 SLC15A4 RPTOR MTNR1B BAIAP3 TAP2 | 3.84e-04 | 420 | 157 | 11 | GO:0042886 |
| GeneOntologyBiologicalProcess | synaptic signaling | NPPA NPY5R DTNA LRRK2 PCDHB3 TPGS1 TSC2 SPG11 ZDHHC3 ADCY1 SLC1A4 ADCY8 ARID1B MTNR1B KCNMA1 IQSEC1 BAIAP3 DAGLA | 4.66e-04 | 976 | 157 | 18 | GO:0099536 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.75e-06 | 17 | 157 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | axon | EXOC6 MYCBP2 DTNA LRRK2 ADGRL1 TPGS1 TSC2 SPG11 ADCY8 ADCY9 LSM1 SLIT2 MRGPRX1 SCN3A SCN5A SCN10A KCNMA1 PLEC DAGLA | 4.12e-05 | 891 | 157 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | sodium channel complex | 6.28e-05 | 29 | 157 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | dendrite | LHFPL4 LRRK2 TPGS1 TSC2 SPG11 PEX5L DENND1A SLC1A4 ADCY8 ADCY9 LSM1 SLIT2 SLC9A5 RPTOR KCNMA1 CACNA1H PLEC DAGLA | 8.19e-05 | 858 | 157 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | LHFPL4 LRRK2 TPGS1 TSC2 SPG11 PEX5L DENND1A SLC1A4 ADCY8 ADCY9 LSM1 SLIT2 SLC9A5 RPTOR KCNMA1 CACNA1H PLEC DAGLA | 8.43e-05 | 860 | 157 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | caveola | 1.93e-04 | 111 | 157 | 6 | GO:0005901 | |
| GeneOntologyCellularComponent | somatodendritic compartment | NPPA LHFPL4 LRRK2 TPGS1 TSC2 SPG11 PEX5L DENND1A SLC1A4 ADCY8 ADCY9 LSM1 SLIT2 SLC9A5 RPTOR MRGPRX1 SCN3A KCNMA1 CACNA1H PLEC DAGLA | 3.54e-04 | 1228 | 157 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | axonemal dynein complex | 8.47e-04 | 25 | 157 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | plasma membrane raft | 8.63e-04 | 147 | 157 | 6 | GO:0044853 | |
| HumanPheno | Left ventricular noncompaction | 3.34e-05 | 19 | 52 | 4 | HP:0030682 | |
| HumanPheno | Abnormal morphology of left ventricular trabeculae | 3.34e-05 | 19 | 52 | 4 | HP:0031192 | |
| HumanPheno | Abnormal morphology of myocardial trabeculae | 4.15e-05 | 20 | 52 | 4 | HP:0030681 | |
| Domain | LRR | 4.47e-05 | 201 | 154 | 9 | PS51450 | |
| Domain | DHHC | 4.91e-05 | 25 | 154 | 4 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 4.91e-05 | 25 | 154 | 4 | IPR001594 | |
| Domain | Na_channel_asu | 6.32e-05 | 10 | 154 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 6.32e-05 | 10 | 154 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 6.32e-05 | 10 | 154 | 3 | PF06512 | |
| Domain | - | LRRC39 NLRP12 LRRC24 ANP32B LRRK2 SLIT2 LRRC53 SLIT1 ZER1 ADGRA3 NLRP13 | 7.38e-05 | 321 | 154 | 11 | 3.80.10.10 |
| Domain | Leu-rich_rpt | LRRC39 NLRP12 LRRC24 ANP32B LRRK2 SLIT2 LRRC53 SLIT1 ADGRA3 NLRP13 | 8.60e-05 | 271 | 154 | 10 | IPR001611 |
| Domain | - | 8.64e-05 | 11 | 154 | 3 | 1.10.730.10 | |
| Domain | L_dom-like | LRRC39 NLRP12 LRRC24 ANP32B LRRK2 SLIT2 LRRC53 SLIT1 ZER1 ADGRA3 NLRP13 | 8.94e-05 | 328 | 154 | 11 | IPR032675 |
| Domain | LRRCT | 1.34e-04 | 32 | 154 | 4 | PF01463 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.87e-04 | 14 | 154 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.87e-04 | 14 | 154 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.87e-04 | 14 | 154 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.87e-04 | 14 | 154 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.87e-04 | 14 | 154 | 3 | IPR011704 | |
| Domain | MT | 1.87e-04 | 14 | 154 | 3 | PF12777 | |
| Domain | AAA_8 | 1.87e-04 | 14 | 154 | 3 | PF12780 | |
| Domain | AAA_5 | 1.87e-04 | 14 | 154 | 3 | PF07728 | |
| Domain | AAA | 1.93e-04 | 144 | 154 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.93e-04 | 144 | 154 | 7 | IPR003593 | |
| Domain | DHC_fam | 2.33e-04 | 15 | 154 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.33e-04 | 15 | 154 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.33e-04 | 15 | 154 | 3 | IPR004273 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 2.33e-04 | 15 | 154 | 3 | IPR009080 | |
| Domain | A/G_cyclase_CS | 3.43e-04 | 17 | 154 | 3 | IPR018297 | |
| Domain | Ion_trans_dom | 3.65e-04 | 114 | 154 | 6 | IPR005821 | |
| Domain | Ion_trans | 3.65e-04 | 114 | 154 | 6 | PF00520 | |
| Domain | aa-tRNA-synth_I_CS | 4.10e-04 | 18 | 154 | 3 | IPR001412 | |
| Domain | - | 4.10e-04 | 18 | 154 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 4.10e-04 | 18 | 154 | 3 | IPR029787 | |
| Domain | Guanylate_cyc | 4.83e-04 | 19 | 154 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.83e-04 | 19 | 154 | 3 | PS50125 | |
| Domain | A/G_cyclase | 4.83e-04 | 19 | 154 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.83e-04 | 19 | 154 | 3 | PS00452 | |
| Domain | CYCc | 4.83e-04 | 19 | 154 | 3 | SM00044 | |
| Domain | AA_TRNA_LIGASE_I | 4.83e-04 | 19 | 154 | 3 | PS00178 | |
| Domain | - | 5.19e-04 | 222 | 154 | 8 | 1.25.10.10 | |
| Domain | ARM-type_fold | MYBBP1A RNPEPL1 LRRK2 TSC2 HSPBP1 TRRAP PAIP1 RPTOR ZER1 STAG3 | 5.19e-04 | 339 | 154 | 10 | IPR016024 |
| Domain | LRR_8 | 5.48e-04 | 171 | 154 | 7 | PF13855 | |
| Domain | ABC_tran | 6.52e-04 | 48 | 154 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.52e-04 | 48 | 154 | 4 | PS50893 | |
| Domain | LRR_TYP | 6.73e-04 | 177 | 154 | 7 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 6.73e-04 | 177 | 154 | 7 | IPR003591 | |
| Domain | ABC_TRANSPORTER_1 | 7.06e-04 | 49 | 154 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 7.62e-04 | 50 | 154 | 4 | IPR003439 | |
| Domain | zf-DHHC | 8.63e-04 | 23 | 154 | 3 | PF01529 | |
| Domain | Na_trans_cytopl | 9.91e-04 | 6 | 154 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 9.91e-04 | 6 | 154 | 2 | IPR024583 | |
| Domain | Val/Leu/Ile-tRNA-synth_edit | 9.91e-04 | 6 | 154 | 2 | IPR009008 | |
| Domain | Anticodon_1 | 9.91e-04 | 6 | 154 | 2 | PF08264 | |
| Domain | M/V/L/I-tRNA-synth_anticd-bd | 9.91e-04 | 6 | 154 | 2 | IPR013155 | |
| Domain | - | 9.91e-04 | 6 | 154 | 2 | 3.90.740.10 | |
| Domain | Channel_four-helix_dom | 1.25e-03 | 57 | 154 | 4 | IPR027359 | |
| Domain | - | 1.25e-03 | 57 | 154 | 4 | 1.20.120.350 | |
| Domain | aa-tRNA-synth_Ia | 1.38e-03 | 7 | 154 | 2 | IPR002300 | |
| Domain | Lipome_HGMIC_fus_partner-like | 1.38e-03 | 7 | 154 | 2 | IPR019372 | |
| Domain | L_HMGIC_fpl | 1.38e-03 | 7 | 154 | 2 | PF10242 | |
| Domain | tRNA-synt_1 | 1.38e-03 | 7 | 154 | 2 | PF00133 | |
| Domain | hEGF | 1.55e-03 | 28 | 154 | 3 | PF12661 | |
| Domain | ARM-like | 1.83e-03 | 270 | 154 | 8 | IPR011989 | |
| Domain | DHC_N1 | 1.83e-03 | 8 | 154 | 2 | PF08385 | |
| Domain | AC_N | 1.83e-03 | 8 | 154 | 2 | IPR032628 | |
| Domain | Adcy | 1.83e-03 | 8 | 154 | 2 | IPR030672 | |
| Domain | AC_N | 1.83e-03 | 8 | 154 | 2 | PF16214 | |
| Domain | Dynein_heavy_dom-1 | 1.83e-03 | 8 | 154 | 2 | IPR013594 | |
| Domain | LRR_1 | 2.30e-03 | 219 | 154 | 7 | PF00560 | |
| Domain | NaH_exchanger | 2.34e-03 | 9 | 154 | 2 | IPR004709 | |
| Domain | GPS | 2.73e-03 | 34 | 154 | 3 | SM00303 | |
| Domain | Leu-rich_rpt_4 | 2.91e-03 | 10 | 154 | 2 | IPR025875 | |
| Domain | LRR_4 | 2.91e-03 | 10 | 154 | 2 | PF12799 | |
| Domain | GPS | 2.97e-03 | 35 | 154 | 3 | PF01825 | |
| Domain | GPS | 3.22e-03 | 36 | 154 | 3 | PS50221 | |
| Domain | GPS | 3.48e-03 | 37 | 154 | 3 | IPR000203 | |
| Domain | Fol_N | 3.54e-03 | 11 | 154 | 2 | IPR003645 | |
| Domain | Cation/H_exchanger_CPA1 | 3.54e-03 | 11 | 154 | 2 | IPR018422 | |
| Domain | Laminin_G_1 | 3.54e-03 | 11 | 154 | 2 | PF00054 | |
| Domain | FOLN | 3.54e-03 | 11 | 154 | 2 | SM00274 | |
| Domain | GPCR_Rhodpsn_7TM | OR8D1 OR10A2 NPY5R OR4D10 CCR9 FPR1 OR8S1 GALR2 MRGPRX1 MTNR1B OR10K2 OR5F1 OR4F15 | 3.71e-03 | 670 | 154 | 13 | IPR017452 |
| Domain | LAM_G_DOMAIN | 3.75e-03 | 38 | 154 | 3 | PS50025 | |
| Domain | 7tm_1 | OR8D1 OR10A2 NPY5R OR4D10 CCR9 FPR1 OR8S1 GALR2 MRGPRX1 MTNR1B OR10K2 OR5F1 OR4F15 | 4.04e-03 | 677 | 154 | 13 | PF00001 |
| Domain | ABC_A | 4.22e-03 | 12 | 154 | 2 | IPR026082 | |
| Domain | MATH | 4.22e-03 | 12 | 154 | 2 | PS50144 | |
| Domain | MATH/TRAF_dom | 4.22e-03 | 12 | 154 | 2 | IPR002083 | |
| Domain | MATH | 4.22e-03 | 12 | 154 | 2 | SM00061 | |
| Domain | MATH | 4.22e-03 | 12 | 154 | 2 | PF00917 | |
| Domain | GPCR_2_extracellular_dom | 4.34e-03 | 40 | 154 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 4.34e-03 | 40 | 154 | 3 | PS00649 | |
| Domain | Laminin_G_2 | 4.34e-03 | 40 | 154 | 3 | PF02210 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 4.34e-03 | 40 | 154 | 3 | PS50227 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8D1 OR10A2 NPY5R OR4D10 CCR9 FPR1 OR8S1 GALR2 MRGPRX1 MTNR1B OR10K2 OR5F1 OR4F15 | 4.46e-03 | 685 | 154 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8D1 OR10A2 NPY5R OR4D10 CCR9 FPR1 OR8S1 GALR2 MRGPRX1 MTNR1B OR10K2 OR5F1 OR4F15 | 4.79e-03 | 691 | 154 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8D1 OR10A2 NPY5R OR4D10 CCR9 FPR1 OR8S1 GALR2 MRGPRX1 MTNR1B OR10K2 OR5F1 OR4F15 | 4.85e-03 | 692 | 154 | 13 | IPR000276 |
| Domain | MIRO-like | 4.96e-03 | 13 | 154 | 2 | IPR013684 | |
| Domain | Roc | 4.96e-03 | 13 | 154 | 2 | PF08477 | |
| Domain | ABC_transporter_CS | 4.99e-03 | 42 | 154 | 3 | IPR017871 | |
| Domain | Rossmann-like_a/b/a_fold | 5.33e-03 | 43 | 154 | 3 | IPR014729 | |
| Domain | - | 5.33e-03 | 43 | 154 | 3 | 3.40.50.620 | |
| Domain | LamG | 5.68e-03 | 44 | 154 | 3 | SM00282 | |
| Domain | P_typ_ATPase_c | 5.76e-03 | 14 | 154 | 2 | IPR032630 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.74e-05 | 10 | 119 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.74e-05 | 10 | 119 | 3 | MM14668 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.99e-04 | 14 | 119 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.99e-04 | 14 | 119 | 3 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.06e-04 | 35 | 119 | 4 | M47969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 2.48e-04 | 15 | 119 | 3 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 2.48e-04 | 15 | 119 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 2.48e-04 | 15 | 119 | 3 | M47504 | |
| Pathway | WP_THERMOGENESIS | 3.03e-04 | 108 | 119 | 6 | M39746 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 3.03e-04 | 16 | 119 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 3.03e-04 | 16 | 119 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.03e-04 | 16 | 119 | 3 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 3.03e-04 | 16 | 119 | 3 | M39849 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 3.66e-04 | 17 | 119 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.66e-04 | 17 | 119 | 3 | M47544 | |
| Pathway | WP_PEPTIDE_GPCRS | 4.24e-04 | 75 | 119 | 5 | M39696 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA4 SLC35C1 ATP8A2 SLC22A11 MCOLN1 ADCY1 SLC1A4 ADCY8 ADCY9 ABCB1 SLC9A2 SLC9A5 ATP8A1 CLCN6 SLC16A1 SLC15A4 | 4.54e-04 | 736 | 119 | 16 | M27287 |
| Pathway | KEGG_ABC_TRANSPORTERS | 5.05e-04 | 44 | 119 | 4 | M11911 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 5.99e-04 | 46 | 119 | 4 | M39828 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 6.02e-04 | 20 | 119 | 3 | M759 | |
| Pathway | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | 6.98e-04 | 21 | 119 | 3 | M15096 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 7.63e-04 | 289 | 119 | 9 | MM15057 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.04e-03 | 24 | 119 | 3 | M47520 | |
| Pubmed | MYCBP2 TNC ADGRL1 PEX5L MCOLN1 SLC1A4 ADCY9 RUSC2 RADIL ATP8A1 SLC16A1 AJM1 RPTOR KCNMA1 IQSEC1 PLEC NLK | 6.15e-13 | 347 | 160 | 17 | 17114649 | |
| Pubmed | Developmental expression of PAM (protein associated with MYC) in the rodent brain. | 9.56e-08 | 3 | 160 | 3 | 12036515 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C RANBP10 LRRC24 MYCBP2 INPPL1 RNPEPL1 ADGRL1 TSC2 RHOT2 TRRAP BIRC6 DENND1A ADCY9 RADIL RPTOR MCM3AP SCN5A ZER1 CACNA1H PLEC | 1.99e-07 | 1105 | 160 | 20 | 35748872 |
| Pubmed | Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. | 2.58e-07 | 57 | 160 | 6 | 17208939 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.92e-06 | 139 | 160 | 7 | 16985003 | |
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 7.87e-06 | 9 | 160 | 3 | 9417641 | |
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 16382098 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 7.87e-06 | 9 | 160 | 3 | 17229090 | |
| Pubmed | 1.08e-05 | 30 | 160 | 4 | 39366945 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.12e-05 | 10 | 160 | 3 | 11884542 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.12e-05 | 10 | 160 | 3 | 8663304 | |
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 16615126 | ||
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 10089566 | ||
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 10808179 | ||
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 11299302 | ||
| Pubmed | Genetic predictors of medically refractory ulcerative colitis. | 1.53e-05 | 11 | 160 | 3 | 20848476 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 10807185 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26146906 | ||
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 2.10e-05 | 2 | 160 | 2 | 24642470 | |
| Pubmed | Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis. | 2.10e-05 | 2 | 160 | 2 | 12015311 | |
| Pubmed | Protective Effect of a Locked Retinal Chromophore Analog against Light-Induced Retinal Degeneration. | 2.10e-05 | 2 | 160 | 2 | 30018116 | |
| Pubmed | Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses. | 2.10e-05 | 2 | 160 | 2 | 16914643 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15745964 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29466724 | ||
| Pubmed | Primary amines protect against retinal degeneration in mouse models of retinopathies. | 2.10e-05 | 2 | 160 | 2 | 22198730 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22184108 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15047701 | ||
| Pubmed | All-trans-retinal induces Bax activation via DNA damage to mediate retinal cell apoptosis. | 2.10e-05 | 2 | 160 | 2 | 24726920 | |
| Pubmed | A neuroprotective phase precedes striatal degeneration upon nucleolar stress. | 2.10e-05 | 2 | 160 | 2 | 23764776 | |
| Pubmed | Calcium-stimulated adenylyl cyclases are critical modulators of neuronal ethanol sensitivity. | 2.10e-05 | 2 | 160 | 2 | 15843614 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18222416 | ||
| Pubmed | Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. | 2.10e-05 | 2 | 160 | 2 | 24231350 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 38745938 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24712709 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 8413268 | ||
| Pubmed | A Combination of G Protein-Coupled Receptor Modulators Protects Photoreceptors from Degeneration. | 2.10e-05 | 2 | 160 | 2 | 29162627 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36226826 | ||
| Pubmed | Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes. | 2.10e-05 | 2 | 160 | 2 | 23626738 | |
| Pubmed | Distinct regional and subcellular localization of adenylyl cyclases type 1 and 8 in mouse brain. | 2.10e-05 | 2 | 160 | 2 | 17335981 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30714145 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28366664 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30918302 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34863682 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10799557 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15985698 | ||
| Pubmed | Retinopathy in mice induced by disrupted all-trans-retinal clearance. | 2.10e-05 | 2 | 160 | 2 | 18658157 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24769171 | ||
| Pubmed | Molecular pharmacodynamics of emixustat in protection against retinal degeneration. | 2.10e-05 | 2 | 160 | 2 | 26075817 | |
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 2.10e-05 | 2 | 160 | 2 | 24998131 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27257073 | ||
| Pubmed | Development of novel cytoprotective small compounds inhibiting mitochondria-dependent cell death. | 2.10e-05 | 2 | 160 | 2 | 37841588 | |
| Pubmed | Calcium activated adenylyl cyclase AC8 but not AC1 is required for prolonged behavioral anxiety. | 2.10e-05 | 2 | 160 | 2 | 27234425 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24360055 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22220722 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25568126 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12620228 | ||
| Pubmed | Ca2+-stimulated ADCY1 and ADCY8 regulate distinct aspects of synaptic and cognitive flexibility. | 2.10e-05 | 2 | 160 | 2 | 37465213 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32330377 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20976279 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14585998 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31665810 | ||
| Pubmed | Prolonged prevention of retinal degeneration with retinylamine loaded nanoparticles. | 2.10e-05 | 2 | 160 | 2 | 25617130 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17121841 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16740475 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12515855 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 35065194 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12441059 | ||
| Pubmed | Protective Effects of Flavonoids in Acute Models of Light-Induced Retinal Degeneration. | 2.10e-05 | 2 | 160 | 2 | 33154094 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20399258 | ||
| Pubmed | Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. | 2.10e-05 | 2 | 160 | 2 | 14631046 | |
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 2.10e-05 | 2 | 160 | 2 | 12200164 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21638318 | ||
| Pubmed | Adenylyl cyclases 1 and 8 initiate a presynaptic homeostatic response to ethanol treatment. | 2.10e-05 | 2 | 160 | 2 | 19479030 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31073029 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10482244 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16943548 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31292628 | ||
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 2.10e-05 | 2 | 160 | 2 | 10432110 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25414195 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31110473 | ||
| Pubmed | zDHHC3-mediated S-palmitoylation of SLC9A2 regulates apoptosis in kidney clear cell carcinoma. | 2.10e-05 | 2 | 160 | 2 | 38619631 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28192797 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19726641 | ||
| Pubmed | A role for calmodulin-stimulated adenylyl cyclases in cocaine sensitization. | 2.10e-05 | 2 | 160 | 2 | 19244515 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23393135 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24706818 | ||
| Pubmed | A lysosomal K+ channel regulates large particle phagocytosis by facilitating lysosome Ca2+ release. | 2.10e-05 | 2 | 160 | 2 | 31974459 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28358418 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23559371 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26069238 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23320558 | ||
| Pubmed | Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons. | 2.10e-05 | 2 | 160 | 2 | 24273493 | |
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 2.10e-05 | 2 | 160 | 2 | 12097499 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15844169 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12072416 | ||
| Pubmed | Manganese-Enhanced MRI for Preclinical Evaluation of Retinal Degeneration Treatments. | 2.10e-05 | 2 | 160 | 2 | 26225634 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19029295 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30038866 | ||
| Pubmed | Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence. | 2.10e-05 | 2 | 160 | 2 | 19160506 | |
| Interaction | SCAP interactions | 3.63e-06 | 121 | 151 | 8 | int:SCAP | |
| Cytoband | 4p15.2 | 1.28e-04 | 28 | 160 | 3 | 4p15.2 | |
| Cytoband | 11q12.2 | 3.46e-04 | 39 | 160 | 3 | 11q12.2 | |
| Cytoband | 7q21-q22 | 5.33e-04 | 10 | 160 | 2 | 7q21-q22 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.05e-05 | 9 | 115 | 3 | 1203 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.91e-05 | 10 | 115 | 3 | 53 | |
| GeneFamily | Dyneins, axonemal | 1.60e-04 | 17 | 115 | 3 | 536 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 2.26e-04 | 19 | 115 | 3 | 131 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 4.60e-04 | 24 | 115 | 3 | 76 | |
| GeneFamily | ATP binding cassette subfamily B | 2.12e-03 | 11 | 115 | 2 | 806 | |
| GeneFamily | ATP binding cassette subfamily A | 3.47e-03 | 14 | 115 | 2 | 805 | |
| GeneFamily | Solute carriers | SLC35C1 SLC22A11 SLC1A4 SLC9A2 SLC9A5 SLC16A1 SLC15A4 SLC4A11 | 3.75e-03 | 395 | 115 | 8 | 752 |
| GeneFamily | ATPase phospholipid transporting | 3.99e-03 | 15 | 115 | 2 | 1210 | |
| GeneFamily | Parkinson disease associated genes | 4.54e-03 | 16 | 115 | 2 | 672 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-07 | 190 | 160 | 8 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-07 | 190 | 160 | 8 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-07 | 190 | 160 | 8 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-07 | 192 | 160 | 8 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.15e-07 | 198 | 160 | 8 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.15e-07 | 198 | 160 | 8 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 169 | 160 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-06 | 171 | 160 | 7 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 3.38e-06 | 175 | 160 | 7 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 3.38e-06 | 175 | 160 | 7 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 178 | 160 | 7 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 3.92e-06 | 179 | 160 | 7 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.23e-06 | 187 | 160 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 5.41e-06 | 188 | 160 | 7 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.87e-06 | 195 | 160 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.87e-06 | 195 | 160 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 8.11e-06 | 200 | 160 | 7 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 8.11e-06 | 200 | 160 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.76e-05 | 163 | 160 | 6 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 2.76e-05 | 163 | 160 | 6 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 167 | 160 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.16e-05 | 167 | 160 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-05 | 168 | 160 | 6 | de0b00bc405c898d08a06b2e585fb62c0ab9a66e | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.27e-05 | 168 | 160 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 168 | 160 | 6 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.38e-05 | 169 | 160 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.61e-05 | 171 | 160 | 6 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 171 | 160 | 6 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-05 | 171 | 160 | 6 | f4321133190a3df9d31f5d4021a464d3840145f1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-05 | 171 | 160 | 6 | ed4fb6c84579d99df33de5f8f928c3cd2f3d3d72 | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.73e-05 | 172 | 160 | 6 | d0cdedd734406988a9a93d7300c7b1a8b4b45c38 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-05 | 173 | 160 | 6 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 179 | 160 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 180 | 160 | 6 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 180 | 160 | 6 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.80e-05 | 180 | 160 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.11e-05 | 182 | 160 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 183 | 160 | 6 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 184 | 160 | 6 | 15cbddea9efb2346a2028d77edfe9ba32923568f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 184 | 160 | 6 | 0087c605c161fd8a39aa394f51994a04e8353bf1 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 184 | 160 | 6 | 968afa6b5ba84169377a24c150bb68749fa674d9 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 184 | 160 | 6 | 920f95625978132c2b6c76654ef6298244103e2d | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 185 | 160 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 186 | 160 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 186 | 160 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 115 | 160 | 5 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 115 | 160 | 5 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 115 | 160 | 5 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 188 | 160 | 6 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 189 | 160 | 6 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | 18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | 144beb01b908f2cd0e04513fb84d817e0c3c124e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.29e-05 | 189 | 160 | 6 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.48e-05 | 190 | 160 | 6 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.48e-05 | 190 | 160 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.49e-05 | 117 | 160 | 5 | 94f511dbf639b164c4b096195db312ecee3ee176 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.67e-05 | 191 | 160 | 6 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.67e-05 | 191 | 160 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.87e-05 | 192 | 160 | 6 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.87e-05 | 192 | 160 | 6 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-05 | 193 | 160 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | (08)_PNEC|World / shred by cell type and Timepoint | 7.69e-05 | 196 | 160 | 6 | 2ee37155c03cd5009427a4bffe6c80ed2ac6939e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 7.91e-05 | 197 | 160 | 6 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.14e-05 | 198 | 160 | 6 | 0f1feed8a37293ae02465909f99548ab58dc7ce5 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 8.60e-05 | 200 | 160 | 6 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 8.60e-05 | 200 | 160 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 200 | 160 | 6 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.60e-05 | 200 | 160 | 6 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Astrocyte|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 7205e742ad796d548761839d92a4794ee8f17629 | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 200 | 160 | 6 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 138 | 160 | 5 | a88c3ae56b0af60f6e87cabade4f21e2bbb336f2 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 141 | 160 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 141 | 160 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 145 | 160 | 5 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.88e-04 | 79 | 160 | 4 | 03c5af851b53800eced1c74e9da374c71092bcd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 150 | 160 | 5 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.15e-04 | 151 | 160 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 152 | 160 | 5 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 152 | 160 | 5 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.22e-04 | 152 | 160 | 5 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-04 | 154 | 160 | 5 | ea5d0da5dd8ccfc19969aec35f044db77d589f54 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 84 | 160 | 4 | 529e270e2974ecc6a2dcdc4dd65f89c88840a58e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-04 | 155 | 160 | 5 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 155 | 160 | 5 | c4dc0fa1d0e657753a56939eb4829fb60382c17f | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 2.43e-04 | 155 | 160 | 5 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-04 | 157 | 160 | 5 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 158 | 160 | 5 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 158 | 160 | 5 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 158 | 160 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 158 | 160 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| Drug | verapamil | CACNA2D1 NPPA ABCA4 TRH ABCA13 BIRC6 ADCY1 ADCY8 ADCY9 ABCB1 RPTOR SCN3A SCN5A SCN10A KCNMA1 CACNA1H TAP2 DNASE1L1 | 1.18e-08 | 490 | 160 | 18 | CID000002520 |
| Drug | cimetidine | TRH ATP8A2 SLC22A11 ADCY1 ADCY8 ADCY9 ABCB1 SLC9A5 CYP2R1 SLC16A1 | 5.77e-07 | 179 | 160 | 10 | CID000002756 |
| Drug | NSC7524 | CACNA2D1 NPPA TRH ADCY1 ADCY8 ADCY9 SCN3A SCN5A SCN10A CACNA1H | 6.72e-07 | 182 | 160 | 10 | CID000005657 |
| Drug | celiprolol | 9.28e-07 | 47 | 160 | 6 | CID000002663 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | CACNA2D1 NPPA NLRP12 CDK14 ADCY1 ADCY8 ADCY9 LSM1 SLC9A2 SLC9A5 KCNMA1 CACNA1H | 1.96e-06 | 308 | 160 | 12 | CID000001915 |
| Drug | hydrochlorothiazide | 2.15e-06 | 120 | 160 | 8 | CID000003639 | |
| Drug | AC1LD8Z3 | 2.50e-06 | 86 | 160 | 7 | CID000644309 | |
| Drug | probenecid | 2.59e-06 | 123 | 160 | 8 | CID000004911 | |
| Drug | bicarbonate | NPPA TRH BIRC6 ADCY1 ADCY8 ADCY9 MELTF SLC9A2 SLC9A5 SLC16A1 PRLR SLC4A11 | 3.42e-06 | 325 | 160 | 12 | CID000000767 |
| Drug | carbamazepine | 5.11e-06 | 179 | 160 | 9 | CID000002554 | |
| Drug | AC1L1TJF | 7.03e-06 | 66 | 160 | 6 | CID000003377 | |
| Drug | alpha-bromoergocriptine | 7.55e-06 | 142 | 160 | 8 | CID000002443 | |
| Drug | 3-isoreserpine | 8.28e-06 | 190 | 160 | 9 | CID000005052 | |
| Drug | NSC759576 | 8.64e-06 | 191 | 160 | 9 | CID000003075 | |
| Drug | DiC8 | 9.25e-06 | 146 | 160 | 8 | CID000001323 | |
| Drug | i-Pr | 1.27e-05 | 73 | 160 | 6 | CID000448400 | |
| Drug | GSK835726 | 1.56e-05 | 22 | 160 | 4 | CID005311268 | |
| Drug | Beraprost-d3 | 1.72e-05 | 77 | 160 | 6 | CID000002352 | |
| Drug | lidocaine | 1.80e-05 | 160 | 160 | 8 | CID000003676 | |
| Drug | AC1L1EV8 | 1.86e-05 | 8 | 160 | 3 | CID000002964 | |
| Drug | Neomigran | 2.16e-05 | 48 | 160 | 5 | CID000003066 | |
| Drug | AC1L8VEV | 2.24e-05 | 24 | 160 | 4 | CID000433433 | |
| Drug | iodide | NPPA NPY5R TRH ATP8A2 FPR1 BIRC6 GALR2 ADCY1 ADCY8 ADCY9 ABCB1 MELTF MTNR1B PRLR | 2.59e-05 | 534 | 160 | 14 | CID000024841 |
| Drug | 14,15-dihydroforskolin | 2.77e-05 | 9 | 160 | 3 | CID000194193 | |
| Drug | cyclaine | 2.77e-05 | 9 | 160 | 3 | CID000010770 | |
| Drug | Mexiletine | 2.77e-05 | 9 | 160 | 3 | ctd:D008801 | |
| Drug | bepridil | 3.11e-05 | 126 | 160 | 7 | CID000002351 | |
| Drug | 2',5'-dd3'-FSBA | 3.94e-05 | 10 | 160 | 3 | CID003081206 | |
| Drug | NC-5Z | 3.94e-05 | 10 | 160 | 3 | CID003035914 | |
| Drug | OD-q | 4.03e-05 | 179 | 160 | 8 | CID000001456 | |
| Drug | 2,4-dinitrophenol | 4.19e-05 | 90 | 160 | 6 | CID000001493 | |
| Drug | tolazoline | 4.86e-05 | 29 | 160 | 4 | CID000005504 | |
| Drug | Hexylcaine | 4.91e-05 | 2 | 160 | 2 | DB00473 | |
| Drug | NSC330500 | 4.91e-05 | 2 | 160 | 2 | CID000433448 | |
| Drug | AC1L40QM | 5.39e-05 | 11 | 160 | 3 | CID000099213 | |
| Drug | B-Mlvp | 5.39e-05 | 11 | 160 | 3 | CID000195648 | |
| Drug | AC1NY9KD | 5.39e-05 | 11 | 160 | 3 | CID005771741 | |
| Drug | NSC-4928 | 5.46e-05 | 58 | 160 | 5 | CID000221086 | |
| Drug | isobutyl nitrite | 5.58e-05 | 30 | 160 | 4 | CID000010958 | |
| Drug | quin2 | 5.69e-05 | 95 | 160 | 6 | CID000104841 | |
| Drug | quinacrine | 5.77e-05 | 243 | 160 | 9 | CID000000237 | |
| Drug | Vasotocin | 5.93e-05 | 59 | 160 | 5 | CID000024774 | |
| Drug | dobutamine | 6.10e-05 | 140 | 160 | 7 | CID000036811 | |
| Drug | propafenone | 6.77e-05 | 98 | 160 | 6 | CID000004932 | |
| Drug | nitrendipine | 6.77e-05 | 98 | 160 | 6 | CID000004507 | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 3229_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 5839_DN | |
| Drug | dopexamine | 7.24e-05 | 32 | 160 | 4 | CID000055483 | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 5405_UP | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 3269_UP | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 4549_UP | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 2265_DN | |
| Drug | Depixol | 8.20e-05 | 33 | 160 | 4 | CID000017011 | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 3626_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 3273_UP | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 3322_UP | |
| Drug | FCE 23884 | 9.25e-05 | 13 | 160 | 3 | CID000065898 | |
| Drug | AC1L1BJN | 9.25e-05 | 13 | 160 | 3 | CID000001467 | |
| Drug | sclareol glycol | 9.25e-05 | 13 | 160 | 3 | CID000091915 | |
| Drug | tetralol | 9.25e-05 | 13 | 160 | 3 | CID000010747 | |
| Drug | nantradol hydrochloride | 9.25e-05 | 13 | 160 | 3 | CID000047652 | |
| Drug | Bay K 8644 | 9.42e-05 | 150 | 160 | 7 | CID000002303 | |
| Drug | S-(-)-Lisuride | 9.46e-05 | 65 | 160 | 5 | CID000003938 | |
| Drug | AC1L1CQC | 9.46e-05 | 65 | 160 | 5 | CID000002012 | |
| Drug | glycylsarcosine | 1.04e-04 | 35 | 160 | 4 | CID000093131 | |
| Drug | chlorthalidone | 1.16e-04 | 36 | 160 | 4 | CID000002732 | |
| Drug | AC1NSKJI | 1.17e-04 | 68 | 160 | 5 | CID005311391 | |
| Drug | fenoldopam | 1.35e-04 | 70 | 160 | 5 | CID000003340 | |
| Drug | gamma-aminobutyric acid | MORC1 CACNA2D1 NPPA TRH DTNA PORCN ZDHHC3 ADCY9 CLCN6 KCNMA1 CACNA1H TAP2 | 1.38e-04 | 474 | 160 | 12 | CID000000119 |
| Drug | amiodarone | 1.41e-04 | 160 | 160 | 7 | CID000002156 | |
| Drug | naltrexone HCl | 1.44e-04 | 71 | 160 | 5 | CID000004428 | |
| Drug | methoxamine | 1.44e-04 | 71 | 160 | 5 | CID000006081 | |
| Drug | SKF 75670 | 1.46e-04 | 15 | 160 | 3 | CID000173870 | |
| Drug | BMY 42393 | 1.46e-04 | 15 | 160 | 3 | CID000131961 | |
| Drug | AC1L2AAS | 1.46e-04 | 15 | 160 | 3 | CID000068714 | |
| Drug | Dibucaine | 1.47e-04 | 3 | 160 | 2 | DB00527 | |
| Drug | TpTpT | 1.54e-04 | 72 | 160 | 5 | CID006441083 | |
| Drug | phenoxybenzamine | 1.64e-04 | 115 | 160 | 6 | CID000004768 | |
| Drug | NSC755875 | 1.70e-04 | 165 | 160 | 7 | CID000002215 | |
| Drug | lamotrigine | 1.72e-04 | 116 | 160 | 6 | CID000003878 | |
| Drug | AC1L1E5T | 1.75e-04 | 74 | 160 | 5 | CID000002653 | |
| Drug | Sulpiride | 1.76e-04 | 40 | 160 | 4 | ctd:D013469 | |
| Drug | nifedipine | CACNA2D1 CYP2A7 NPPA TRH BIRC6 ABCB1 GGT5 CYP2R1 KCNMA1 FADS2 CACNA1H | 1.77e-04 | 415 | 160 | 11 | CID000004485 |
| Drug | Ts-I | 1.87e-04 | 75 | 160 | 5 | CID000445278 | |
| Drug | NSC186061 | 1.89e-04 | 118 | 160 | 6 | CID000004163 | |
| Drug | AC1NIP3C | 1.94e-04 | 41 | 160 | 4 | CID004834553 | |
| Drug | AC1L1I54 | 1.94e-04 | 41 | 160 | 4 | CID000004426 | |
| Drug | gabapentin | 1.97e-04 | 169 | 160 | 7 | CID000003446 | |
| Drug | N-arachidonoylethanolamine | 2.04e-04 | 226 | 160 | 8 | CID000002185 | |
| Drug | San 21009 | 2.15e-04 | 17 | 160 | 3 | CID000152662 | |
| Drug | Zonisamide | 2.15e-04 | 17 | 160 | 3 | DB00909 | |
| Drug | U754 | 2.15e-04 | 17 | 160 | 3 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 2.15e-04 | 17 | 160 | 3 | CID000084008 | |
| Drug | AC1L1B9H | 2.25e-04 | 78 | 160 | 5 | CID000001341 | |
| Drug | atenolol | 2.26e-04 | 122 | 160 | 6 | CID000002249 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CACNA2D1 NPPA NLRP12 ABCA4 CDK14 ADCY1 ADCY8 ADCY9 LSM1 MTNR1B KCNMA1 CACNA1H DNAH9 | 2.28e-04 | 577 | 160 | 13 | CID000000295 |
| Drug | amrinone | 2.34e-04 | 43 | 160 | 4 | CID000003698 | |
| Drug | naphthalene | 2.37e-04 | 123 | 160 | 6 | CID000000931 | |
| Drug | TMB-8 | 2.53e-04 | 176 | 160 | 7 | CID000005494 | |
| Drug | sumatriptan | 2.53e-04 | 80 | 160 | 5 | CID000005358 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Atrial standstill | 2.67e-05 | 2 | 153 | 2 | C0541782 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.91e-05 | 12 | 153 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Brugada Syndrome 1 | 3.76e-05 | 13 | 153 | 3 | C4551804 | |
| Disease | delta-6 desaturase measurement | 5.94e-05 | 15 | 153 | 3 | EFO_0007765 | |
| Disease | P wave duration | 5.94e-05 | 15 | 153 | 3 | EFO_0005094 | |
| Disease | CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE | 7.99e-05 | 3 | 153 | 2 | C1838539 | |
| Disease | autosomal recessive nonsyndromic deafness 67 (implicated_via_orthology) | 7.99e-05 | 3 | 153 | 2 | DOID:0110518 (implicated_via_orthology) | |
| Disease | regulator of G-protein signaling 18 measurement | 7.99e-05 | 3 | 153 | 2 | EFO_0801995 | |
| Disease | protein kinase c iota type measurement | 7.99e-05 | 3 | 153 | 2 | EFO_0020681 | |
| Disease | QRS complex, QRS duration | 8.78e-05 | 45 | 153 | 4 | EFO_0005054, EFO_0005055 | |
| Disease | Brugada ECG Pattern | 1.59e-04 | 4 | 153 | 2 | C1721096 | |
| Disease | inosine-5'-monophosphate dehydrogenase 1 measurement | 1.59e-04 | 4 | 153 | 2 | EFO_0008158 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 8 measurement | 1.59e-04 | 4 | 153 | 2 | EFO_0802179 | |
| Disease | epilepsy (implicated_via_orthology) | 2.14e-04 | 163 | 153 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Brugada Syndrome (disorder) | 2.55e-04 | 24 | 153 | 3 | C1142166 | |
| Disease | nephrolithiasis (implicated_via_orthology) | 2.64e-04 | 5 | 153 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | Sudden death | 2.64e-04 | 5 | 153 | 2 | C0011071 | |
| Disease | dihomo-gamma-linolenic acid measurement | 3.65e-04 | 27 | 153 | 3 | EFO_0007763 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement | 3.95e-04 | 6 | 153 | 2 | EFO_0800434 | |
| Disease | electrocardiography | MYCBP2 FPR1 RHOT2 ZFC3H1 RADIL CLCN6 SCN5A SCN10A PLEC WDR49 | 4.67e-04 | 530 | 153 | 10 | EFO_0004327 |
| Disease | electrocardiography, PR interval | 5.51e-04 | 7 | 153 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 5.52e-04 | 31 | 153 | 3 | C1335167 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 6.07e-04 | 32 | 153 | 3 | EFO_0010363 | |
| Disease | DNA methylation | SCFD2 ILRUN ABCA13 CDK14 BMP7 FRY UBE3D MTNR1B KCNMA1 CACNA1H DNAH6 | 6.53e-04 | 656 | 153 | 11 | GO_0006306 |
| Disease | phosphatidylcholine 38:5 measurement | 6.65e-04 | 33 | 153 | 3 | EFO_0010387 | |
| Disease | language measurement | 6.85e-04 | 134 | 153 | 5 | EFO_0007797 | |
| Disease | heart function measurement | 7.27e-04 | 34 | 153 | 3 | EFO_0004311 | |
| Disease | adult onset asthma, type 2 diabetes mellitus | 7.33e-04 | 8 | 153 | 2 | EFO_1002011, MONDO_0005148 | |
| Disease | protein-tyrosine sulfotransferase 2 measurement | 7.33e-04 | 8 | 153 | 2 | EFO_0801971 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 7.92e-04 | 35 | 153 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Depressive disorder | 8.07e-04 | 289 | 153 | 7 | C0011581 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 9.39e-04 | 9 | 153 | 2 | OBA_2045127 | |
| Disease | level of Phosphatidylcholine (16:0_22:4) in blood serum | 9.39e-04 | 9 | 153 | 2 | OBA_2045078 | |
| Disease | supraventricular ectopy | 9.39e-04 | 9 | 153 | 2 | EFO_0009277 | |
| Disease | lysophosphatidylcholine 20:3 measurement | 1.17e-03 | 40 | 153 | 3 | EFO_0010362 | |
| Disease | Other specified cardiac arrhythmias | 1.42e-03 | 11 | 153 | 2 | C0348626 | |
| Disease | Shortened QT interval | 1.42e-03 | 11 | 153 | 2 | C0151879 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 1.42e-03 | 11 | 153 | 2 | OBA_2045197 | |
| Disease | delta-5 desaturase measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0007764 | |
| Disease | Nodal rhythm disorder | 1.42e-03 | 11 | 153 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 1.42e-03 | 11 | 153 | 2 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 1.42e-03 | 11 | 153 | 2 | C2748542 | |
| Disease | Endometrioma | 1.55e-03 | 161 | 153 | 5 | C0269102 | |
| Disease | Endometriosis | 1.55e-03 | 161 | 153 | 5 | C0014175 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.70e-03 | 12 | 153 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 1.70e-03 | 12 | 153 | 2 | OBA_2045157 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.79e-03 | 99 | 153 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | COVID-19, mortality | 1.97e-03 | 170 | 153 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.99e-03 | 102 | 153 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 2.01e-03 | 13 | 153 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | phosphatidylcholine 40:7 measurement | 2.01e-03 | 13 | 153 | 2 | EFO_0021477 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 2.01e-03 | 13 | 153 | 2 | OBA_2045116 | |
| Disease | Pain, Crushing | 2.11e-03 | 49 | 153 | 3 | C0458259 | |
| Disease | Pain, Splitting | 2.11e-03 | 49 | 153 | 3 | C0458257 | |
| Disease | Pain | 2.11e-03 | 49 | 153 | 3 | C0030193 | |
| Disease | Pain, Migratory | 2.11e-03 | 49 | 153 | 3 | C0751407 | |
| Disease | Suffering, Physical | 2.11e-03 | 49 | 153 | 3 | C0751408 | |
| Disease | Radiating pain | 2.11e-03 | 49 | 153 | 3 | C0234254 | |
| Disease | Pain, Burning | 2.11e-03 | 49 | 153 | 3 | C0234230 | |
| Disease | Ache | 2.11e-03 | 49 | 153 | 3 | C0234238 | |
| Disease | Mental Depression | 2.16e-03 | 254 | 153 | 6 | C0011570 | |
| Disease | Metabolic Bone Disorder | 2.33e-03 | 14 | 153 | 2 | C0005944 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0022085 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 2.33e-03 | 14 | 153 | 2 | OBA_2045100 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 2.33e-03 | 14 | 153 | 2 | OBA_2045143 | |
| Disease | lysophosphatidylcholine 22:5 measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0021462 | |
| Disease | T wave morphology measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0008398 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 2.33e-03 | 14 | 153 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.33e-03 | 14 | 153 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | body mass index, fasting blood glucose measurement | 2.37e-03 | 51 | 153 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | Squamous cell carcinoma of the head and neck | 2.51e-03 | 52 | 153 | 3 | C1168401 | |
| Disease | Epilepsy | 2.54e-03 | 109 | 153 | 4 | C0014544 | |
| Disease | Peroxisome biogenesis disorders | 2.68e-03 | 15 | 153 | 2 | C1832200 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.68e-03 | 15 | 153 | 2 | C0428908 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 2.68e-03 | 15 | 153 | 2 | OBA_2041208 | |
| Disease | Situs ambiguus | 2.68e-03 | 15 | 153 | 2 | C0266642 | |
| Disease | Osteopenia | 2.68e-03 | 15 | 153 | 2 | C0029453 | |
| Disease | pathological myopia | 2.71e-03 | 111 | 153 | 4 | EFO_0004207 | |
| Disease | Neuralgia, Supraorbital | 3.06e-03 | 16 | 153 | 2 | C0038870 | |
| Disease | Romano-Ward Syndrome | 3.06e-03 | 16 | 153 | 2 | C0035828 | |
| Disease | Paroxysmal Nerve Pain | 3.06e-03 | 16 | 153 | 2 | C0751373 | |
| Disease | Nerve Pain | 3.06e-03 | 16 | 153 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 3.06e-03 | 16 | 153 | 2 | C0751371 | |
| Disease | Neuralgia | 3.06e-03 | 16 | 153 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 3.06e-03 | 16 | 153 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 3.06e-03 | 16 | 153 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 3.06e-03 | 16 | 153 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 3.06e-03 | 16 | 153 | 2 | C0423711 | |
| Disease | Neuralgia, Vidian | 3.06e-03 | 16 | 153 | 2 | C0042656 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 3.08e-03 | 115 | 153 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | response to lithium ion | 3.10e-03 | 56 | 153 | 3 | GO_0010226 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 3.45e-03 | 17 | 153 | 2 | EFO_0021049 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.56e-03 | 195 | 153 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 3.87e-03 | 18 | 153 | 2 | OBA_2045110 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 3.87e-03 | 18 | 153 | 2 | OBA_2045065 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 3.87e-03 | 18 | 153 | 2 | OBA_2045079 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 3.87e-03 | 18 | 153 | 2 | EFO_0010365 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASILINFLGAILNIL | 791 | P40145 | |
| FLLLLAFQLLGQTRA | 11 | P01160 | |
| SGNISGFIRRLFLQL | 3801 | Q9NR09 | |
| GQFGFQRLDLRLLES | 3381 | Q7Z408 | |
| FILELFENNRTLLRF | 1811 | P78363 | |
| SAFSEFGLQLLRQLR | 506 | O94812 | |
| INLFLAELLFLVGID | 901 | O94910 | |
| ADIFRGLTNLVRLNL | 146 | Q8IWK6 | |
| FLNFNVAFALALLVL | 311 | Q9H6U8 | |
| AFVSLLVEFGANLNL | 251 | Q9Y576 | |
| SADNFLRFGLEGLLL | 761 | C9J069 | |
| LRDFLVALGNALVSV | 1231 | Q86UQ4 | |
| LFLLNLAFLVNVGSG | 316 | Q86Y34 | |
| FNLSQLSGFLELLVE | 1741 | Q8NFD5 | |
| FVNLEFLSLINVGLI | 41 | Q92688 | |
| DNVKLFLFQLLRGLS | 231 | O94921 | |
| LFLLRSALADFSLDN | 21 | P18075 | |
| DLITFNLRNFLLFQL | 6 | Q13536 | |
| GLNFLTFIILFNNLI | 341 | Q9Y2Q0 | |
| QIRRAANAFFLFIAL | 91 | Q9NTI2 | |
| IILFGRELQALSEQL | 511 | Q6VN20 | |
| FDLLNLNRLISGIDN | 96 | Q5JSJ4 | |
| ILGFQATNERLFVLT | 556 | Q96RS6 | |
| NTHLNELLLFIIAGF | 191 | Q8WZ84 | |
| ILFGLSNQLAVTFRE | 81 | Q9GZU1 | |
| NSNLFSLLFLALGII | 751 | P08183 | |
| SFLFGALAELLDNAR | 26 | Q86VD1 | |
| FFFSGTLLLNQLLDR | 641 | Q96JH8 | |
| EFLFLGDILGLALQN | 761 | Q6IE37 | |
| ILGALLFLNFIRFLE | 316 | O95864 | |
| QFLDLTLFTHRGFLL | 251 | P53985 | |
| VLLFLGILLFEAQHS | 456 | P59901 | |
| IELNRQSLLSRGFLL | 1436 | Q5T1H1 | |
| ALRLIQFSEILQFLN | 276 | Q12791 | |
| VGLQNFFSLFLLLAA | 526 | Q6ZRQ5 | |
| LFNLALLSLSRNGIE | 56 | A6NM62 | |
| LSFAQVRLLEGNFSL | 111 | Q9H9K5 | |
| LGLHQREIFLFNDLL | 771 | Q6DN90 | |
| GAIIELFNSVLQFLA | 1606 | O60318 | |
| LRNAGNLFLVSLALA | 71 | P49286 | |
| FIGRFQNLIVLDLSR | 101 | Q96DD0 | |
| TGLQSLLQGFSRLFL | 46 | Q9UK85 | |
| SFLLILALGQAVQFQ | 11 | Q9NR23 | |
| RTLIGFLRSIDQFAN | 26 | O15116 | |
| LINFLIFLQRGKFAT | 151 | P28328 | |
| LFQAANLGDLDVLLR | 606 | Q8IYB4 | |
| GNQLARLLDFTFLHL | 131 | Q50LG9 | |
| RLTLGNFFNILVLNE | 276 | Q5S007 | |
| NLFGLAFSLNGVELL | 186 | Q8TCT9 | |
| FAELLGRRILFQAQS | 331 | Q9UBE8 | |
| GLTNSREIQLLLFVF | 16 | Q8NGB8 | |
| FFIGVFLALVLNLLQ | 36 | Q9Y5U4 | |
| NALILSFLAFVLGNR | 186 | Q7Z7J7 | |
| SFLAFVLGNRQTDLL | 191 | Q7Z7J7 | |
| GDTLQLAFIDLRQLL | 711 | Q8TAG9 | |
| NLFGVLALFQSGRLV | 136 | Q9BQG0 | |
| LQVGLRELLNALFSN | 296 | Q9H074 | |
| ALEGFFESLAIQLLQ | 161 | Q9NYR8 | |
| RNLSFLEIGFNLVIV | 51 | Q9H208 | |
| FIELNSTLFLLRFIN | 426 | P51843 | |
| RALNLLFGALAIFHL | 396 | Q9H237 | |
| LLLLGELQALRDFAQ | 246 | Q96A29 | |
| NLFILNLGVADLCFI | 61 | O43603 | |
| QVGQLALLFSLTFAL | 121 | Q08828 | |
| LALSLLELLGFNLTF | 126 | P51797 | |
| FERLNALAAIVQGSL | 1356 | Q9C0G6 | |
| SNFLRILENSIRLGL | 3106 | Q9C0G6 | |
| VLISEFQRLLGFQLN | 26 | Q9H6K1 | |
| ALLFLILANGAQAFR | 6 | P49184 | |
| LINRVLLDAGFTNEL | 701 | P54289 | |
| LLAFTRQALNLPDVF | 316 | Q9Y3I1 | |
| QLLRFAIATLRDFGV | 126 | P20853 | |
| GALFLLLFALGVRQL | 16 | Q6VVX0 | |
| FLLNLAIADLLFLVT | 86 | P51686 | |
| DLIAFLNEAALANLL | 101 | Q6UWU2 | |
| ILSFILNVLRGFNFS | 291 | P36269 | |
| LLVFALTLAAQFQVL | 181 | O60503 | |
| FLSRGLALNVDLLLF | 391 | Q674R7 | |
| LSQLEGFRRQLLDVL | 531 | Q9Y4D2 | |
| LQLFKQFIDGRLDLL | 361 | Q8TEH3 | |
| QSISLLLNFLLAAFD | 106 | Q9Y4J8 | |
| SIDNLLLNGFFLAIE | 886 | Q9NYC9 | |
| IFNLRDFANIFQGIL | 2676 | Q9NYC9 | |
| NIGLRAFLVIADSLQ | 496 | Q5TBA9 | |
| LFNLLVAILVEGFQA | 1006 | O95180 | |
| DLQSLGRDIFLLQAL | 366 | Q9NSA0 | |
| LLQALFGAVDFLGRA | 376 | Q9NSA0 | |
| FFLLAAIQGATLLLF | 536 | Q8N697 | |
| FRNFLLLASSLLFAG | 6 | O95965 | |
| QTSLRQFLGLFDLSL | 3841 | Q8TE73 | |
| GLADTLELQIILFLF | 16 | O95221 | |
| QRQVLLLFVFLGGSL | 11 | Q9Y5E6 | |
| EVIFLGFSSLARLQQ | 11 | Q6IF99 | |
| GLTQNREVSLVLFLF | 16 | Q8NGI6 | |
| AGLLQFLRLDGFSVL | 221 | Q9NZL4 | |
| NAFILGLLNIRSLEF | 1106 | Q8N2Y8 | |
| AFLGNLVSAQTVFLR | 131 | Q9NYV6 | |
| FFQRLELGDVQALSL | 226 | Q5T160 | |
| NALRFILNALGEKFV | 751 | Q5ST30 | |
| LANQAGLDAFRIFLK | 26 | Q2M5E4 | |
| RTFQTALFLDRLLDG | 561 | Q9HAU8 | |
| FTGLQVLQLLLLCAF | 816 | Q8NBS3 | |
| QLLLERFLNRAAVAF | 141 | Q9H741 | |
| LIFRLLNEGQRLFSH | 291 | P08582 | |
| LTLDGFLFLNTLFIQ | 246 | Q8IXI1 | |
| VNFLIGNLAFSDILV | 76 | Q15761 | |
| DINLFGSVFLIALIA | 106 | P21462 | |
| LLLQALDGFLFVVNR | 116 | Q9Y6Q9 | |
| GNLVVLNLFLALLLS | 926 | Q14524 | |
| RLLSLGDRQLNAFDI | 581 | O15357 | |
| RVQAGLLDFLLFGSL | 166 | Q14940 | |
| REQLFSSLLRQDLGF | 226 | Q03519 | |
| GFQFTATLLDLERLR | 1446 | O75592 | |
| LQLVAALERQIFDFL | 16 | Q4KMZ8 | |
| LRNTLRFLLGNVADF | 726 | Q9NSE4 | |
| DNFLAFERLLLQSIG | 426 | Q8WU76 | |
| GNLVVLNLFLALLLS | 971 | Q9NY46 | |
| LNLAAADFLFLSGRL | 66 | Q96LB2 | |
| SAGEFQLIRQTLLIF | 161 | Q8WVF1 | |
| LGFLDALINVLLAVN | 151 | Q8NH09 | |
| LFRQDLLVASLFRNF | 336 | Q8N122 | |
| LLVASLFRNFLLAER | 341 | Q8N122 | |
| IDSFQIILDSLLLFG | 216 | Q96A09 | |
| DSLLNFLQHLREFGL | 256 | Q92759 | |
| LILFGLTQEEFLNRL | 491 | Q96JI7 | |
| LLFQLSVFCLFNRLL | 741 | Q9UNS1 | |
| QAFSLLELDGINLRL | 246 | Q8N2E2 | |
| LQFLGLFENSLCRLT | 326 | Q7Z7L7 | |
| SIINGIVFNLLAFLA | 76 | Q9NYG2 | |
| FLLLNQLFQIAFLGL | 536 | Q8IUH4 | |
| QEQAFVLLSDLLLIF | 796 | Q9UJ98 | |
| AFGLSDITLLQNLLF | 196 | Q9UBY0 | |
| GTIHFLRLINNLFDI | 506 | Q9H5L6 | |
| FLDLARNLFPSNLVV | 171 | P43007 | |
| LAGEGLFTLSLNIRF | 176 | Q8N1Q8 | |
| VLNLFIALLLNSFSA | 881 | Q9Y5Y9 | |
| FIRRDFLLDEANGLL | 136 | Q6IQ16 | |
| FIRRDFLLDEANGLL | 136 | O43791 | |
| FLEVRGQLQSALLIL | 11 | Q7Z6J8 | |
| LENFRNLAILGLLVS | 31 | Q96K75 | |
| GRLFISFNNQLALLA | 121 | Q8IV35 | |
| QLLAGVFLAFLALAT | 6 | P24821 | |
| FTLLLFLNTCLLNGQ | 11 | P16471 | |
| GRLGQALLLYLFNLA | 86 | Q7L0L9 | |
| GLDLENSFSNILLFV | 76 | Q8IYM2 | |
| AAELGLDFQRFLTLN | 56 | Q9H3T2 | |
| ALLLRATFYLLIGNA | 331 | O94826 | |
| SLFEGLFSLQLLLLN | 366 | O94813 | |
| VARLLLEAQAATGFL | 3856 | Q15149 | |
| AFLGNLVSAQTVFLR | 131 | A6NIE6 | |
| AILQQLRDRLLANGF | 661 | Q8TEA7 | |
| FLLQDSGRILQLLAE | 891 | Q9NNW5 | |
| FFALSGIAAQLLNAL | 96 | Q9BVC6 | |
| RALQLALAAFQLLNL | 51 | Q6UX98 | |
| GLDDFLRQVERLLFL | 41 | P20396 | |
| QFLVDLLSALGFRRV | 181 | Q9H5U6 | |
| QLNIVLIDFGLSFIS | 176 | Q96S44 | |
| LRALQPFQVGDLLFS | 21 | Q9NRG4 | |
| AFRALRGLEVLTLNN | 176 | O75093 | |
| LLEFVARAGALFQLL | 191 | Q6ZTW0 | |
| LALIGFAEFVLHLNR | 3676 | Q9Y4A5 | |
| NILSFQLLEALLFRV | 1471 | O60293 | |
| RLQAFDFLLLLRADS | 611 | P49815 | |
| LLNDLTQGLLRADFL | 31 | Q86YQ2 | |
| LILSFLAFVLGNRQD | 201 | Q86UP9 | |
| LALTSRFLFGLLNEE | 556 | P59046 | |
| LFFFGLLNKNIAREL | 586 | Q86W25 |